The antigenic specificities of the membrane antigen (MA) complex on three Epstein-Barr (EB) virus-producing cell lines have been compared by complete absorption of an anti-MA antiserum with P3HR-1 cells, followed by testing for residual anti-MA antibody activity against B95-8 and QIMR-WIL cells. Indirect membrane immunofluorescence showed that the absorbed serum, which had lost the capacity to bind P3HR-1 cells, nevertheless gave bright staining on a small proportion of B95-8 cells. SDS-polyacrylamide gel electrophoretic analysis of 125I-labelled MA polypeptides showed that the absorbed serum was able to isolate MA polypeptides from both B95-8 and QIMR-WIL cells, but not from P3HR-1 cells. The results demonstrate that there is substantial sharing of antigenic specificities between the MA determined by three isolates of EB virus, and some antigenic divergence.
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Short communications sequence (Bornkamm et al., 1980) , it is natural to speculate that these differences in MA reflect genetic variations. In view of the observed tool. wt. differences, we have investigated whether antigenic differences exist between the MA molecules displayed by three EB virus-producing cell lines: P3HR-1, a human cell line derived from a case of Burkitt's lymphoma (Jijoye) (Henle et al., 1967) --it should be noted that after these cells were cloned, they produced virus which had lost the transforming ability (Miller et al., 1974) characteristic of all other EB virus isolates; B95-8, a marmoset lymphoblastoid cell line established using virus from an individual with perfusion mononucleosis (Miller et al., 1972) ; and QIMR-WlL, a human lymphoblastoid cell line of the type obtainable from any individual seropositive for EB virus, although the donor suffered from myeloblastic leukaemia (Pope, 1968) . The present communication describes experiments in which serum (HS18) from a normal human MA-seropositive donor (kindly provided by the Southwest Regional Blood Transfusion Centre, Bristol, U.K.) was absorbed with P3HR-l cells until all subsequent indirect membrane immunofluorescence with these was abolished; after this, the absorbed serum was tested for indirect membrane immunofluorescence on B95-8 cells, and for the ability to isolate 125I-labelled MA polypeptides from B95-8 and QIMR-WlL cells. A monoclonal antibody designated 72A1 (generously made available by Dr G. J. Hoffman, Johns Hopkins School of Medicine, Baltimore, U.S.A.) (Hoffman et al., 1980) has also been used to isolate ~5I-labelled MA polypeptides, while a seronegative human serum (HS 15) served as a control.
Details of the methods of cell culture, cell surface radioiodination using Na125I and lactoperoxidase, immune complex isolation and SDS-polyacrylamide gel electrophoretic (SDS-PAGE) analysis of 12SI-labelled MA polypeptides, have been described in full elsewhere (North et al., 1980) . Mol. wt. standards used in SDS-PAGE were purchased from Pharmacia: thyroglobulin (330000), ferritin (220000), phosphorylase b (94000), bovine serum albumin (67000) and trypsinogen (24000). Indirect membrane immunofluorescence tests were carried out following established procedures (Klein et aL, 1967 ) using a FITC conjugate of sheep anti-human IgG (Wellcome Reagents).
HS 18 serum was absorbed repeatedly with P3HR-1 cells at a ratio of 109 cells/ml serum diluted 1 : 3. For each absorption, a pellet of washed cells was resuspended in the appropriate volume of diluted serum and incubated with gentle agitation for 30 min at 20 °C, followed by 2 h at 4 °C. Cells were removed by centrifugation at 350 g for 10 rain, and the absorbed serum clarified by centrifugation at 30000 g for 30 min, After each absorption, the serum was tested by indirect immunofluorescence for its ability to give membrane staining of P3HR-1 cells, and no further MA staining on P3HR-1 cells could be detected following seven sequential absorptions.
In previous experiments using indirect membrane immunofluorescence, it was observed that P3HR-1 and QIMR-WlL cells showed MA fluorescence as two to four bright patches/ positive cell. In contrast, cells from B95-8 cultures showed either one to 30 weakly fluorescent spots or very bright staining over the whole plasmalemma. The first type of staining involved between I0 and 75% of the population and the second type, from 1 to 5 % of the population; the more virus produced by a culture, the greater the number of cells showing each staining pattern. All the staining was readily distinguishable from the fluorescence of dead cells.
When HS18 serum was used after absorption with P3HR-1 cells to stain B95-8 cells, the indirect immunofluorescence of the cells showing spot staining was markedly reduced (Fig.  1 a) , whereas that of the small proportion of cells with staining over the whole surface remained essentially unchanged (Fig. 1 b) . The results suggest that the cells of B95-8 cultures showing both full surface fluorescence and, to a lesser extent, the spot staining, have antigenic specificities not found on P3HR-1 ceils. To determine whether this antigenic difference between the MA complex of P3HR-1 and B95-8 cells was related to the previously established differences in the mol. wt. of the MA polypeptides from these sources (North et al., 1980) , the absorbed serum was tested for its ability to isolate MA polypeptides from each of three cell lines. Tracks A and J of Fig. 2 show that as previously reported (North et al., 1980) , HS 18 serum binds three components of MA from P3HR-1 and QIMR-WIL cells. By contrast, the absorbed HS18 serum was unable to isolate any of the three major MA components of P3HR-1 (Fig. 2, track C) , thus confirming the findings from the indirect immunofluorescence tests. Nevertheless, the absorbed serum was able to isolate a small proportion of the 340000 mol. wt. polypeptide from a B95-8 lysate (Fig. 2 , tracks D and G) and of both the 320000 and 240000 mol. wt. polypeptides from a QIMR-WIL lysate (Fig. 2, track L ). An 85 000 mol. wt. component of MA isolated from P3HR-1, QIMR-WIL and B95-8 cell lysates with HS18 serum, was not isolated from P3HR-1 or B95-8 lysates after absorption of the serum. However, the absorbed serum did isolate a proportion of the 85 000 mol. wt. MA polypeptides from QIMR-WIL (Fig. 2, track  L) . Thus, no antigenic difference was detected between the 85000 mol. wt. components of P3HR-1 and B95-8 MA, although the QIMR-WIL 85 000 mol. wt. MA polypeptide possesses antigens not found on P3HR-1 cells.
Absorption of much of the antibody to the 340000 mol. wt. component of B95-8 MA by P3HR-1 cells displaying predominantly a 240000 mol. wt. polypeptide, suggests substantial sharing of antigenic determinants between these molecules. The presence of common antigens is unequivocally demonstrated by the ability of a monoclonal antibody, derived by cell fusion techniques from mice immunized with B95-8 EB virus (Hoffman et al., 1980) , to isolate both 320000 and 240000 mol. wt. MA components from P3HR-1 cells (Fig. 2, track M) as well as a high mol. wt. polypeptide from B95-8 cells (track N). The electrophoretic mobility of the MA component isolated in this laboratory from B95-8 cells using 72A 1 monoclonal antibody is indistinguishable from that isolated using human seropositive serum HS 18, giving a mol. wt. of 340000 (North et al., 1980) . It is likely that the B95-8 M A polypeptide observed by Hoffman et al. (1980) using this antibody (put at 250000 mol. wt.) is identical to the 340000 mol. wt. MA species described here, the absence of a mol. wt. standard above 220000 contributing to the lower mol. wt. quoted (Hoffman et al., 1980) . Two other monoclonal antibodies to M A also isolate both of the high mol. wt, M A polypeptides from QIMR-WIL, B95-8 and P3HR-1 cells (Thorley-Lawson & Geilinger, 1980 ; J. R. North, unpublished data using the antibody of Thorley-Lawson & Geilinger, 1980) . It is therefore apparent that the two high mol. wt. MA polypeptides on each cell line are structurally related both to one another and to the equivalent components in the M A of the other EB virus-producing cell lines tested. Nevertheless, the incomplete absorption of antibodies to B95-8 and Q I M R -W I L M A by P3HR-1 ceils indicates antigenic divergence between the M A determined by these particular isolates of EB virus. M A components are known to be glycoproteins (Thorley-Lawson & Edson, 1979; Qualti6re & Pearson, 1979 Strnad et aL, 1979) , but it is at present unclear whether the antigenic differences detected here result from alterations in the polypeptide or carbohydrate portions of the molecules, Although the species of origin of the host cell appears to contribute to the mol. wt. of EB virus-determined M A polypeptides (North et al., 1980) , other factors must influence the antigenic difference since both P3HR-1 and Q I M R -W I L cells are of human origin.
Short communications
Although there is as yet no biological, immunological or biochemical evidence for disease-related strain differences amongst EB virus isolates (Kawai et al., 1973 ; N o n o y a m a & Short communications 375 Pagano, 1973; Kieff & Levine, 1974; Menezes et al., 1975; Miller et al., 1976; Pagano et al., 1976; Gerber et al., 1976; Fialkow, 1976; Kaschka-Dierich et al., 1977; Sugden, 1977; Adams et al., 1979; Rymo et al., 1979; Bornkamm et al., 1980) , it has long been known that the P3HR-1 and B95-8 strains are anomalous. Thus, P3HR-1 EB virus is the only strain known to have lost transforming ability (Gerber et al., 1969; Miller et al., 1974) and to have marked perturbations of genome structure (Raab-Traub et al,, 1978 : Bornkamm et al., 1980 , whilst the B95-8 strain of the virus lacks at least 10% of the usual viral DNA (Raab-Traub et al., 1978; Delius & Bornkamm, 1978; Given & Kieff, 1978; Bornkamm et al., 1980) . If the antigenic variation in MA reported here is not in fact due to differences in host cell-directed glycosylation of virus-determined polypeptides, it seems probable that the variation may reflect one aspect of the differences in DNA size and organization known to occur amongst anomalous strains of EB virus.
